Cafepharma Today

October 17 2024 - Sage lays off half of R&D team, shakes up C-suite again
Sage lays off half of R&D team, shakes up C-suite again
Sanofi inks $326M radiopharma deal with Orano
Novartis loses latest bid to block generic version of blockbuster heart drug
Kezar to discontinue mid-stage trial for lupus treatment
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Is Dendreon a $360 Stock - Or Is That Too Low?
Seeking Alpha
Friday, April 24, 2009 - 10:01am
tags:
Dendreon, Provenge
Abbott Laboratories: Dividend Stock Analysis
Seeking Alpha
Friday, April 24, 2009 - 9:59am
tags:
Abbott Laboratories
Illumina, Inc (ILMN): Zacks Rank Buy
Yahoo/Zacks.com
Friday, April 24, 2009 - 8:38am
tags:
Illumina
GSK Slides Away From Innovation
InVivo
Friday, April 24, 2009 - 8:33am
tags:
GSK, dermatology
King Pharma CEO's pay falls by nearly half in 2008
Yahoo/AP
Friday, April 24, 2009 - 8:18am
tags:
King, Brian Markison, Pharma CEOs
Pfizer shareholders back advisory vote on exec pay
Yahoo/AP
Friday, April 24, 2009 - 8:16am
tags:
Pfizer
Can Merck Maintain Its Profitability as a Low Cost Drug Producer?
Seeking Alpha
Friday, April 24, 2009 - 8:11am
tags:
Merck
Why I Doubt the FDA Will Approve Acorda's Fampridine
Seeking Alpha
Friday, April 24, 2009 - 6:14am
tags:
Acorda Therapeutics, FDA, Fampiridine, antihypertensives
Amgen Profit Falls, Misses Estimates
TheStreet.com
Friday, April 24, 2009 - 6:12am
tags:
Amgen, earnings
FDA Extends Bristol Diabetes Drug Deadline
TheStreet.com
Friday, April 24, 2009 - 6:11am
tags:
FDA, diabetes, Bristol-Myers Squibb, Onglyza
The Next Cancer Bestseller?
Forbes
Friday, April 24, 2009 - 6:10am
tags:
Novartis, Gleevec, leukemia, kidney cancer, Afinitor
Worldwide, consumers prefer generics, says study
Medical Marketing and Media
Thursday, April 23, 2009 - 10:07am
tags:
generics
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thursday, April 23, 2009 - 10:04am
tags:
FDA, drug trials, Acorda Therapeutics, GTx, Alkermes
U.S. Drug Sales Projected to Decline This Year
WSJ Online
Thursday, April 23, 2009 - 9:50am
tags:
drug sales
FDA Calendar Updates: Diabetes
Seeking Alpha
Thursday, April 23, 2009 - 9:48am
tags:
FDA, diabetes, Bristol-Myers Squibb, AstraZeneca, Onglyza, alogliptin, Takeda, Novo Nordisk, Victoza
Solvay: Yes, we're reviewing our strategies
Fierce Pharma
Thursday, April 23, 2009 - 9:27am
tags:
Solvay
Gilead Sciences: A Biotech No More
Seeking Alpha
Thursday, April 23, 2009 - 9:26am
tags:
Gilead Sciences, biotech
Pay for Performance for Prescription Drugs (Or Maybe Not)
WSJ Online
Thursday, April 23, 2009 - 9:22am
tags:
Januvia, Cigna, Merck, diabetes
Teva acquisition rumor pushes Watson trade
Globes,Israel
Thursday, April 23, 2009 - 8:31am
tags:
Teva Pharmaceuticals, Watson Pharmaceuticals, buyouts
Bristol-Myers, AstraZeneca drug approval delayed
Marketwatch
Thursday, April 23, 2009 - 8:26am
tags:
Bristol-Myers Squibb, FDA, AstraZeneca, Onglyza, diabetes

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline
Induced Proximity, in the Lab and in the Clinic
In the Pipeline
If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?
Drug Channels
Half-Full and Half-Empty AI Glasses
In the Pipeline
As MFP Approaches, Transparency Is More Important Than Ever
Drug Channels
Long, Slow Stories
In the Pipeline
Coronavirus Vaccination: Room for Improvement
In the Pipeline
Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond
Drug Channels
The 2024 Chemistry Nobel: Computational Protein Design
In the Pipeline

Latest Jobs

Virtual Lead Generation & Sales Specialist - Pharmaceuticals
Jacksonville, Florida, 32290
Syneos Health/ inVentiv Health Commercial LLC
Neuroscience Account Manager (Psychiatry) - Pensacola, FL
Pensacola, Florida, 32573
Vanda Pharmaceuticals
Structural Heart/ICE Territory Sales Manager, Northwest
Issaquah, Washington, 98027
Siemens Medical Solutions USA, Inc
Sales Executive
Everett, Washington, 98213
Abel Consulting
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Territory Account Manager
Orange, California, 92613
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement, CNS - Charlottesville, VA
Roanoke, Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago W, IL
Chicago, Illinois,
Otsuka
Pharmaceutical Sales Customer Engagement- Corpus Christi, TX
Corpus Christi, Texas,
Otsuka
Hearing Aid Sales Consultant
Barrington, Rhode Island, 02806
Beltone New England
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information